{"url":"https://lda.senate.gov/api/v1/filings/873bdc99-c8d2-4d3f-9d01-9cbbb221f269/","filing_uuid":"873bdc99-c8d2-4d3f-9d01-9cbbb221f269","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2025,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/873bdc99-c8d2-4d3f-9d01-9cbbb221f269/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Dan Elling","dt_posted":"2025-04-18T15:38:37-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"25 Mass. Ave. NW #500-H","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":401106196,"url":"https://lda.senate.gov/api/v1/registrants/401106196/","house_registrant_id":null,"name":"FEDERAL HEALTH POLICY STRATEGIES","description":"Government affairs consulting","address_1":"25 Mass. Ave. NW #500-H","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RUDY MISSMAR","contact_telephone":"+1 202-448-1647","dt_updated":"2026-07-30T13:34:39.130107-04:00"},"client":{"id":212007,"url":"https://lda.senate.gov/api/v1/clients/212007/","client_id":125,"name":"PFIZER","general_description":"Pharmaceutical Company","client_government_entity":false,"client_self_select":null,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-09-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Implementation of the drug pricing provisions in the Inflation Reduction Act Drug pricing and prescription digital therapeutics","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":108236,"prefix":null,"prefix_display":null,"first_name":"DAN","nickname":null,"middle_name":null,"last_name":"ELLING","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}